The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine

Por Gee, Siobhan, Taylor, David
Publicado no Ther Adv Psychopharmacol (2020)

Inflammatory response to clozapine in the absence of myocarditis: case report

Por Davey, Patrick, Gee, Siobhan, Shergill, Sukhi S.
Publicado no BJPsych Open (2016)

Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment

Por Gee, Siobhan, Dixon, Thomas, Docherty, Mary, Shergill, Sukhwinder S
Publicado no BMC Psychiatry (2015)

Factors predicting use of laxatives in outpatients stabilized on clozapine

Por Bailey, Loren, Varma, Seema, Ahmad, Nina, Gee, Siobhan, Taylor, David M.
Publicado no Ther Adv Psychopharmacol (2015)

Management of clozapine treatment during the COVID-19 pandemic

Por Gee, Siobhan, Gaughran, Fiona, MacCabe, James, Shergill, Sukhi, Whiskey, Eromona, Taylor, David
Publicado no Ther Adv Psychopharmacol (2020)

Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit

Por Gee, Siobhan H., Taylor, David M., Shergill, Sukhwinder S., Flanagan, Robert, MacCabe, James H.
Publicado no Ther Adv Psychopharmacol (2016)

Clozapine prescribing in COVID-19 positive medical inpatients: a case series

Por Butler, Matthew, Bano, Felicity, Calcia, Marilia, McMullen, Isabel, Sin Fai Lam, Chun Chiang, Smith, Laura Jane, Taylor, David, Gee, Siobhan
Publicado no Ther Adv Psychopharmacol (2020)